Hinge Health, Inc.

1. 01

   Set a 52-week high on 4 Nov 2026

   Closed at $120.87 on 4 Nov 2026: 3.3% below the 52-week high of $124.94 (4 Nov 2026) and 301.8% above the low of $30.08 (9 Feb 2026).

   Daily price bars, split-adjusted · as of 4 Nov 2026

2. 02

   Ahead of SPY and its sector fund XLK over 1 year

   1 month: +22.9% (SPY −1.6%, XLK −12.6%). 3 months: +49.6% (SPY −0.4%, XLK −5.1%). 1 year: +126.2% (SPY +13.6%, XLK +20.1%). Price change to the 4 Nov 2026 close; dividends excluded.

   Daily closes, split-adjusted: HNGE, SPY and XLK · as of 4 Nov 2026

3. 03

   Volume 2.3× its 30-session average on 3 Nov 2026

   3 Nov 2026 volume of 4.2M shares was 2.3× the average of the 30 sessions before it (1.9M), as the price rose 1.2%. SPY traded 0.8× its own average that session.

   Daily volume against a 30-session baseline · as of 3 Nov 2026

4. 04

   Above its 50- and 200-day averages

   The 4 Nov 2026 close of $120.87 was 21.0% above its 50-day average ($99.87) and 77.3% above its 200-day average ($68.18). It has closed above the 200-day for 129 sessions, since 4 May 2026. The 50-day average crossed above the 200-day on 4 Jun 2026, 106 sessions ago.

   Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026

5. 05

   RSI(14) at 74.7, 70 or above

   The 14-session relative strength index closed at 74.7 on 4 Nov 2026, its 2nd session at 70 or above. By convention a reading of 70 or above is called overbought and 30 or below oversold.

   Daily closes, split-adjusted; Wilder's 14-session RSI · as of 4 Nov 2026

At the 4 Nov 2026 close